lobbying_activities: 1346518

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1346518	c3fad43c-d400-4556-861e-3be1b880c455	Q4	BROWN RUDNICK LLP	287895	HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC	2012	fourth_quarter	PHA	H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011; S.2297 relating to hydrocodone rescheduling. H.R. 5853 - Gray Market Drug Reform and Transparency Act of 2012	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2013-01-18T17:04:50.850000-05:00